This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by REID, R. L. Articles by YEN, S. S. C. Search for Related Content PubMed PubMed Citation Articles by REID, R. L. Articles by YEN, S. S. C.

The Disappearance of Opioidergic Regulation of Gonadotropin Secretion in Postmenopausal Women^*

R. L. REID, M. E. QUIGLEY and S. S. C. YEN

Department of Reproductive Medicine, University of California, San Diego, School of Medicine (T-002) La Jolla, California 92093

In postmenopausal women, the administration of β-endorphin in repeated pulses (1–2.5 mg) at 1- to 2-h intervals or constant infusion (1 mg/h) for 3–6 h elicited the prompt release of PRL without concomitant change in LH levels. Infusion of an opiate receptor antagonist, naloxone (1.6 mg/h), for 6–7 h also had no effect on LH levels. Since substantial evidence indicates that endogneous opioid peptides exert an inhibitory role on GnRH-LH secretion and that the functional activity of opiate receptors appears to be ovarian steroid dependent, the present observation suggests that the hypersecretion of gonadotropin in the absence of ovarian steroid feedback may, in part, be causally related to a reduced opioid inhibition of GnRH-LH release.

^* This work was supported by NIH Grant HD-12303 and in part by the UCSD General Clinical Research Center NIH/Division of Research Resources (Grant RR-00827). This research was conducted in part by the Clayton Foundation for Research, California Division.

Fellow in Reproductive Endocrinology supported by the Medical Research Council of Canada.

Clinical Physician, General Clinical Research Center, UCSD.

Investigator for the Clayton Foundation. To whom all correspondence and requests for reprints should be addressed.

Received February 10, 1983.

This article has been cited by other articles:

				B. Litschauer, G. Schaller, and M. Wolzt Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2120 - H2125. [Abstract] [Full Text] [PDF]

				Y. R. Smith, J.-K. Zubieta, M. G. del Carmen, R. F. Dannals, H. T. Ravert, H. A. Zacur, and J. J. Frost Brain Opioid Receptor Measurements by Positron Emission Tomography in Normal Cycling Women: Relationship to Luteinizing Hormone Pulsatility and Gonadal Steroid Hormones J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4498 - 4505. [Abstract] [Full Text]

				J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen Pulsatile Luteinizing Hormone Secretion in Patients with Addison's Disease. Impact of Glucocorticoid Substitution J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 736 - 743. [Abstract] [Full Text]